For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2021/02/opportunities-for-vision-in-healthcare-a-presentation-from-woodside-capital/ Vini Jolly, Executive Director at Woodside Capital, presents the “Vision Opportunities in Healthcare” tutorial at the September 2020 Embedded Vision Summit. With advances in computer vision, AI/ML and data analytics, the pace of technological change continues to accelerate. Nowhere has the confluence of those technologies been more impactful than in Digital Health. Healthcare is an almost $4 trillion industry and continues to grow every year. But by some estimates about 25% of the overall healthcare spend ($1T!) is wasted. This presentation not only examines the investment trends in digital health, but also dives into the specific verticals and domains where startups are leveraging computer vision and AI to disrupt healthcare by addressing efficiency, efficacy and hopefully affordability.

1. © 2020 Woodside Capital Partners
Vision Opportunities in
Healthcare
Vini Jolly
September 2020

2. © 2020 Woodside Capital Partners
Artificial Intelligence AutoTech Report Collaborative Robots
Digital Health
Introduction to WCP
2
M&A, strategic
partnerships, and
corporate finance
advisory
Focused on
emerging growth
technology
companies
Founded in 2001:
over $8 billion in
transaction value
Offices in Silicon
Valley, London,
Shanghai
Dedicated Digital
Health and
Computer Vision
corporate finance
practice

3. © 2020 Woodside Capital Partners
Key Thoughts
3
Healthcare Market Is
Massive And Growing
CV Startup Ecosystem
Is Thriving
(Investments, Policy,
Strategics)
Computer Vision +
Healthcare =
A Natural Fit
Digital Health Is Hot!
(Despite The
Pandemic)

4. © 2020 Woodside Capital Partners
Embedded Vision / Visual AI Market Map
4
Camera Modules
Sensors Illumination Lenses
Cameras Processors Boards
and Modules
Processors and SoCs Software
Memory
Enabling Services &
Tools
Development Tools Image & Video Data Standards
Components
Subsystems
Open Source
Design & Manufacturing
Services
Silicon IP
Automotive
Tier 1 Suppliers
Consumer
Retail
Transportation
Industrial Security &
Surveillance
Defense & Aerospace
Communication Media & Entertainment
Agriculture
Healthcare
Enabling
Technologies
Systems
&
Solutions

5. © 2020 Woodside Capital Partners
Market Size – US Health Spending
Healthcare spending is expected to increase significantly from $3.5 tn in 2017 to $5.9 tn in 2027
5
United States, 1967 to 2017, Selected Years, and 10-year Projection
$52 $174
$517
$1,135
$2,295
$3,492
$5,963
$0
$1,000
$2,000
$3,000
$4,000
$5,000
$6,000
$7,000
1967 1977 1987 1997 2007 2017 2027P
Billions
Source: CMS.gov

6. © 2020 Woodside Capital Partners
US Healthcare Spending Per Capita (1960- 2020)
Per capita healthcare spending in the US is expected to grow from $11,597 in 2018 to $12,118 in 2020
6
1. Xxx
Source: Statista
146
355
1,108
2,843
4,857
6,875
7,071
7,423
7,845
8,141
8,412
8,649
8,908
9,113
9,518
9,995
10,379
10,379
11,172
11,597
12,118
0 2,000 4,000 6,000 8,000 10,000 12,000 14,000
1960
1980
2000
2006
2008
2010
2012
2014
2016
2018
2020¹

7. © 2020 Woodside Capital Partners
US Healthcare Spending by Categories (%)
Nursing Care, Prescription Drugs, Physician/Clinical Care and Hospital Care are expected to show greatest %
increase in healthcare spending in the US during 2024-2028
7
Source: S&P
5.6
6.0
5.6
5.9
4.8
4.4
7.1
4.5
5.1
4.4
3.2
3.9
4.6
6.6
4.6
4.5
4.1
2.5
1.4
4.6
5.2
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0
National Health Expenditures
Hospital Care
Physician and Clinical Care
Prespricption Drugs
Nursing Care Facilities and Continuing
Care Retirement Communities
Dental Services
Home Healthcare
2018 2019 2024-2028

8. © 2020 Woodside Capital Partners
US Healthcare Spending – Key Facts
US per capita healthcare spending has increased over 2018; however, the quality of healthcare is still not as
expected
8
Source: CMS.gov, US Federal Government Spending, Fortune
USD3.8 tn
Estimated total healthcare spending
in 2019
USD1.7 tn
Total US Federal State and Local
Govt. healthcare spending in 2019
4.8%
Growth in
spending over 2018
5.5%
Estimated growth in spending
during 2018 - 2027
59%
Spending goes to hospitals, doctors,
and clinical services
USD11,597
Estimated per capita healthcare
spending in 2019
17.7%
GDP share related to healthcare
spending
25%
Of all medical spending
goes to waste
40,000 – 80,000
Number of deaths
due to misdiagnosis

9. © 2020 Woodside Capital Partners
Benefits of Computer Vision in Healthcare
CV is allowing medical practitioners to offer more precise, on-time, and cost-effective diagnostic and monitoring
services that are enhancing the overall healthcare service delivery model
9
Source: Med City News, Logikk
Health
Monitoring
• Enables doctors to
remotely monitor,
analyze health
metrics, and take
faster and better
medical decisions
Precise
Diagnoses
• Accurate diagnoses of
image data
• Reduce redundant
surgical procedures
and expensive
therapies
Timely Detection
of Illness
• Early detection of
symptoms
• Timely treatment
• Increased probability
of survival
Reduce Drug
Development Costs
• Enables
pharmaceutical
companies to increase
throughput
Improved
Patient Care
• Saves time in
analyzing reports and
images
• Allows doctors to
spend more time with
patients and provide
more personalized
care

10. © 2020 Woodside Capital Partners
Computer Vision in Healthcare Applications
The continuous involvement of CV in healthcare has created new areas of applications
10
Source: Health Tech Magazine
Medical Imaging/Diagnostics
• Radiology
• Pathology
• Oncology
• Dermatology
• Ophthalmology
• Cardiology
• Neurology
• Lab Diagnostics
• Genomics
Drug Discovery
• Visualization
• High Throughput Target Simulation
• Cellular Level Analysis
Remote Monitoring & Care
• Facial Analytics
• Pharma/Clinical Trial Adherence
• Child Monitoring
• Physical Therapy
• Pain Management
Remote/Robotic Surgery
• AR/VR/Mixed Reality
• Remote Surgical Applications
• Other Application: Cardio/Lung/Hernia

11. © 2020 Woodside Capital Partners
Source: CB Insights
Healthcare Startups - Computer Vision Market Map
11
Imaging & Diagnostics Drug Discovery
Genomics
Virtual Assistant
Remote/Patient Monitoring
Clinical Trials Nutrition
Fitness Mental Health
Compliance Wearables

12. © 2020 Woodside Capital Partners
Source: Tractica, Maximize Market Research
Global Computer Vision in Healthcare Market by
Application
12
$200M
$3,450.3M
$0
$875
$1,750
$2,625
$3,500
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
$
Millions
Medical Imaging & Diagnostics Surgeries Patient management and Research Clinical trials Other Application
CAGR 42.8%
CV in healthcare is expected to show continuous growth with medical imaging and diagnostics to contribute the most towards overall
market growth

13. © 2020 Woodside Capital Partners
U.S. Digital Healthcare Venture Funding
13
Source: Rock Health Funding Database
Note: Only includes U.S. deals >$2M; data through June 30, 2020
$4.6B
$5.8B
$8.2B
$7.4B
$5.4B
$0B
$2B
$4B
$6B
$8B
$10B
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2016 2017 2018 2019 2020
Despite the pandemic (or perhaps due to it), 2020 might see the highest venture capital infusion into Digital Health ever!
Digital health venture funding 2016-H1 2020

14. © 2020 Woodside Capital Partners
Computer Vision in Healthcare Venture Funding
14
Source: Pitchbook
$1 $1 $8
$27 $22 $27
$139
$218
$493
1 1 6 7 9 12 12 24 26
2011 2012 2013 2014 2015 2016 2017 2018 2019
Funding ($M) # of Deals
VC funding for CV in healthcare increased significantly from $218 mn in 2018 to $493 mn in 2019

15. © 2020 Woodside Capital Partners
Cutting Edge Computer Vision Healthcare Companies
15
Source: Crunchbase
Zebra Medical Vision, Caption Health and Sight are few of the trailblazing CV startups
Bringing AI and Deep Learning to pathology to deliver accurate diagnoses
AI for radiology (CT and X-ray) to detect abnormalities and speed time to diagnoses for everything from bone density to cranial bleeding
AI and Cloud Supercomputing for fast, accurate image analysis especially for cardiovascular and lung conditions
Brings affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving
healthcare for all
AI-enabled acquisition and interpretation of ultrasounds
Securely stream patient photographs and wound analysis on the desktop
Designer of a medical imaging device that reduces the cost of real-time and 3D imaging and treatment
Non-invasive coronary artery disease detection using 3D image rendering
Machine vision based facial analysis to identify patient adherence
Machine vision to analyze movement and falls for patients/seniors
Using contact free sensing technology for remote monitoring

16. © 2020 Woodside Capital Partners
Source: Company Websites, Secondary Research
Centralized vs. Remote Data Acquisition
16
Centralized Data Acquisition & Analytics
Point of Care/Remote Data Acquisition & Analytics
Lab Diagnostic Cardiology Ultrasound DNA Testing MRI CT Scan
Opthalmology Crib Cam Remote Monitoring Lab Diagnostics Dermatology Bio-monitoring

17. © 2020 Woodside Capital Partners
Best Funded Companies in Computer
Vision Healthcare (1/2)
17
Source: CapitalIQ
Caption Health, Nanit, Healthy.io, AiCure are some of the major diagnostics solution providers that are more inclined towards CV-driven innovation
Company
Name
Deal
Date
Company
Stage
Overview
Recent Funding
($M)
Pre-money
Valuation ($M)
Caption Health 07/15/2020 Series B
AI and deep learning-based medical imaging software for
intelligent video analysis to diagnose heart diseases
$53.00
Nanit 05/12/2020 Series B1
AI and computer vision-based monitoring devices designed to
track baby sleep behavior and patterns
$21.00 $42.00
Arterys 05/06/2020 Series C
Medical imaging analytics platform with AI to visualize and
quantify blood flow in the body using an MRI
$28.00 $16.00
Owkin 05/06/2020 Series A
ML tool to augment medical and biological research integrating
biomedical images, genomics and clinical data
$43.00
Arterys 04/28/2020 Series C
SaaS-based analytics and medical imaging diagnostics used to
visualize and quantify blood flow in the human body
$28.00

18. © 2020 Woodside Capital Partners
Best Funded Companies in Computer
Vision Healthcare (2/2)
18
Source: CapitalIQ
Caption Health, Nanit, Healthy.io, AiCure are some of the major diagnostics solution providers that are more inclined towards CV-driven innovation
Company
Name
Deal
Date
Company
Stage
Overview
Recent Funding
($M)
Pre-money
Valuation ($M)
AiCure 11/07/2019 Series C
AI-based intelligent software to capture and understand video,
audio, and behavioral data for disease treatment
$24.50
Healthy.io 09/11/2019 Series C
Computer vision and AI-based platform to capture test strip
images using smartphone camera, analyze chemical color of
urine test strips and give instant reports
$60.00 $192.42
Zebra Medical
Vision
08/01/2019 Series C
ML-based medical imaging research and analytics platform to
provide automated medical image diagnosis
$39.26 $94.31
Tempus 05/30/2019 Series F
Developer of a health care data analytics platform designed to
improve patient outcomes
$200.00 $3,100.00
PathAI 04/17/2019 Series B
Developer of an AI-powered research platform for cancer
diagnosis and treatment
$60.00

19. © 2020 Woodside Capital Partners
Key Portfolio Companies of Major Investors (1/2)
19
Source: 3DS, Medical Device Network, Francisco Partners, WellSoft, Point Click Care, Secondary Research
General Atlantic, Bessemer Ventures, Khosla Ventures, and Google Ventures are some of the major investors in healthcare specific CV
Investors Key Portfolio Companies
Khosla Ventures HealthTap, Zebra Medical Vision, Curai, Arpeggio Bioscience, Olive (RPA)
DCVC Zymergen, Culture Bioscience, CloudMedx, ProteinQure, HumanDx, Caption Health
Andreessen
Horowitz
TwoAR, Freenome
Google Ventures
Flatiron, Insitro, Verana Health, Owkin, Fathom (Medical Coding Automation), DxOptics, ImagenTechnologies, Recursion
Pharmaceuticals, Atomwise
General Catalyst Mindstrong Health, OM 1, Curai, Imprivata, Color, Roman Health, Avant-Grade Health, Aidin, Humedica, Prematics
General Atlantic
Change Healthcare, EviCore Healthcare, Eclipsys, MultiPlan, Envoy, Amedes Group, CitrusTech, Change Healthcare, Alignment
Healthcare, Capario, OneOncology, eRx Network, MedUnite, Healthcare Technology Management Services, MeDIStar Group
Polaris
OM 1, Gauss Surgical, Imprivata, Phytel, Phreesia, Free & Clear, Quartet Health, Partsource, Perpetual Motion, Prospex Medical,
Sentillion, Strata Health Solutions, Wellsphare

20. © 2020 Woodside Capital Partners
Key Portfolio Companies of Major Investors (2/2)
20
Source: 3DS, Medical Device Network, Francisco Partners, WellSoft, Point Click Care, Secondary Research
General Atlantic, Bessemer Ventures, Khosla Ventures, and Google Ventures are some of the major investors in healthcare specific CV
Investors Key Portfolio Companies
Digitix Savonix, Tissue Analytics, Siris Medical, WellDoc
Canaan Abyrx, Ambra, Anliva Biosciences, Arrakis Therapeutics, Arvinas, Corvium, Genome Medical, Glooko, Roman, Truveris, Vineti
Bessemer Ventures
AccuVein, Artemis Health, Bright Health, Collective Medical, Docent Health, Fractyl, Groups, Kymera Therapeutics, Nym, Qventus,
Subtle Medical, TScan Therapeutics

21. © 2020 Woodside Capital Partners
Big Tech Transforming Healthcare (1/2)
21
Source: Google, Healthcare Weekly, CNBC, TheVerge
Large data companies like Google, Amazon and Apple are making huge strides into healthcare as technological advancements have enabled digital healthcare to
advance rapidly
• Most active big tech firm in healthcare AI
initiatives
• Founded Verily in 2015
• Project Medical Digital Assist focused on AI
usage in physician assistance
• Developed algorithm to diagnose diabetic
retinopathy in images
• Acquired fitness activity tracker Fitbit for $2.1
billion
• Partnered with biotech firms C4 Therapeutics
and AbbVie pharmaceuticals via Calico
• Corporate healthcare system –
Amazon Care
• Purchased online pharmacy
startup PillPack
• Plans to sell medical records
reading software
• Working on cancer research and other
healthcare related ventures such as last-mile
delivery
• Focus on patient facing products
as well as streamlining medical payments
• Received FDA clearance for new heart
monitoring Apple Watch feature (EKG)
• Implementing Apple Health Records system
through hospital partnerships
• Acquired sleep monitor company Beddit (May
2017) and personal health data platform
Gliimpse (2016)

22. © 2020 Woodside Capital Partners
Big Tech Transforming Healthcare (2/2)
22
Source: Microsoft, Becker Shopital Review, The Verge, Telegraph, Company Websites
The healthcare industry presents tremendous business opportunity, encouraging other top tech companies to adopt healthcare innovation
• Launched health care division in 2017 that focuses on AI
for patient care improvement
• Alliance with Walgreens to develop new health care
innovations
• Offering healthcare focused solutions through Azure
suite
• Collaborative research on applying
AI to MRI scans
• Acquires neural interface startup CTRL-Labs for its mind-
reading wristband
• Plans to launch “Preventive Health” tool to prompt users
to get regular checkups
• Acquired predictive healthcare technology business of
BioSensics
• Bought seniors-focused health services company Critical
Signal Technologies and GreatCall, emergency concierge
& monitoring services provider
• Acquired Auris Health’s robotic platform technology
used in diagnostic and lung therapeutic procedures
• Partnered with accelerator Founders Factory with focus
on startups in the consumer healthcare space
• Intel Capital invested in Lumiata, which improves quality
of hospital care through data and predictive analytics
• Invested in EchoPixel, which is developing tools to enable
non-invasive colon cancer screening
• Launched Uber Health: non-medical-emergency
transportation service

23. © 2020 Woodside Capital Partners
FDA Gears for Innovation in
Medical Technology
23
Source: Technology Review, MedTech Boston, FDA, Healthcare IT News
As shift towards new technologies gains momentum, the FDA has worked to modernize their regulatory approach to facilitate
innovation to improve the healthcare system
Proposed regulatory
framework for
dynamic AI systems to
ensure realization of the full potential of
the technology
Approval of 106 novel devices
in 2018, including artificial
intelligence
based technologies
for diabetic
retinopathy diagnosis
Creation of a Center for
Excellence for Digital Health to
complement the advances in
software-based devices
Digital Health Innovation Action Plan 2017
• Regulatory exclusion of certain medical software and lifestyle mobile apps under the
revised 21st Century Cures Act
• Development of a precertification program for faster launches for certain products
(including AI based products)
• Growing FDA’s medical software technology expertise through talent hiring

24. © 2020 Woodside Capital Partners
Future Trends
24
Key Trends
FDA will continue to embrace Software as a Medical Device (SaMD) to approve diagnoses
Precision medicine: Closed loop from drug discovery to therapy, adherence/compliance and
efficacy
Automation: Oncology/Radiology/Pathology will become increasingly automated as AI/DL
algorithms continue to improve
Portable devices and smart phones or smart phone-based peripherals will continue to
“consumerize” healthcare
Combination of AI/ML/DL + high resolution imaging/capture will continue to democratize
CV, especially in lab diagnostics
5G will enable distributed computing and push the real-time analytics envelope

25. © 2020 Woodside Capital Partners
Important Disclosure
25
The Information and opinions in this report have been prepared by Woodside Capital Partners International, LLC, and its affiliate, Woodside Capital Securities, LLC (collectively, “Woodside”).
All information supplied or obtained from this report is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to
buy or sell a security, or a recommendation or an endorsement by Woodside Capital Securities, LLC, Woodside Capital Partners International, LLC and Woodside Capital Partners UK, LLP of
any security. Further information on any of the securities mentioned in this report may be obtained from our offices. Other than disclosures relating to Woodside Capital Securities, LLC the
information herein is based on sources we believe to be reliable but is not guaranteed by us and does not purport to be a complete statement or summary of the available data. Any opinions
expressed herein are statements of our judgment on this date and are subject to change without notice. Periodic updates may be provided on companies/industries based on company
specific developments or announcements, market conditions or any other publicly available information.
Important Disclosures
Woodside Capital Securities, LLC is not a market maker in any securities mentioned in this report.
Woodside Capital Securities, LLC and their officers and employees may from time to time acquire, hold, or sell a position in the securities mentioned in this report. Woodside Capital
Securities, LLC compensates individuals for activities and services intended to benefit the firm's investor clients. Compensation determinations for individuals, including the author(s) of this
report, are based on a variety of factors, and may include the overall profitability of the firm and the revenues derived from all sources, including revenues from investment banking.
Woodside Capital Securities, LLC is a registered broker-dealer and member of FINRA (www.finra.org) and SIPC (www.sipc.org).
Woodside Capital Securities, LLC is an affiliate of Woodside Capital Partners International, LLC and Woodside Capital Partners UK, LLP.
One or more private companies in this report have confidentially retained Woodside Capital Securities, LLC, Woodside Capital Partners International, LLC or Woodside Capital Partners UK,
LLP as an advisor. In addition, in the future Woodside may seek to offer investment banking services to, and collect fees from, any of the companies featured in this report.
Third Party Disclosures
Any analyst opinions, ratings, and public company reports included in this report are provided by third-parties unaffiliated with Woodside Capital Securities, LLC, Woodside Capital Partners
International, LLC and Woodside Capital Partners UK, LLP. Woodside Capital Securities, LLC, Woodside Capital Partners International, LLC and Woodside Capital Partners UK, LLP makes no
guarantees that information supplied is accurate, complete, updated or timely, and does not provide any warranties regarding results obtained from its use.

26. © 2020 Woodside Capital Partners
Thank you
Vini.jolly@woodsidecap.com